Plasma levels of leptin and IL-1β were significantly modulated during the development of MetS and OA, correlated with clinical parameters of MetS and OA, and may play a critical role in the pathogenesis of MetS-related OA. The gene discussed is LEP; the disease is metabolic syndrome.